Discover open access scientific publications

Search, annotate, share and cite publications

Publications by T. Leal

P3.04-08 Identifying Resistance to Immune Checkpoint Inhibitors by Screening for PD-L1 and MHC I Expression on CTCs in PTS With NSCLC

Journal of Thoracic Oncology

English

Kaposi Sarcoma—An Unusual Cause of Asymptomatic Anemia

Indian Journal of Gastroenterology

Gastroenterology

2018

English

Related publications

P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

P3.04-20 Correlation of Immune-Related Adverse Events and Response From Immune Checkpoint Inhibitors in Patients With Advanced NSCLC

Journal of Thoracic Oncology

English

P3.04-14 TMB and Immune Checkpoint Inhibitor Gene Expression Are Unrelated in NSCLC Patients

Journal of Thoracic Oncology

English

P1.04-16 Comparison of Clinical Response to Checkpoint Inhibitors in Advanced NSCLC With High PD-L1 Expression Tested on Cytology Versus Biopsy Samples

Journal of Thoracic Oncology

English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

English

MA19.08 Detection of Primary Immunotherapy Resistance to PD-1 Checkpoint Inhibitors (PD1CI) in 2nd Line NSCLC

Journal of Thoracic Oncology

English

Prognostic Impact of Tumor Cell PD-L1 Expression and Immune Cell Infiltration in NSCLC

Journal of Thoracic Oncology

English

P3.04-04 Prognostic Value of MHC-I, PD-L1 and CD8+ TILs Expressions in Patients With Surgically Resected Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P1.01-08 Hyperresponsive Disease: A New Pattern of Response in NSCLC Patients Treated by Anti-Pd-1/Pd-L1

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by T. Leal

P3.04-08 Identifying Resistance to Immune Checkpoint Inhibitors by Screening for PD-L1 and MHC I Expression on CTCs in PTS With NSCLC

Kaposi Sarcoma—An Unusual Cause of Asymptomatic Anemia

Related publications

P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)

P3.04-20 Correlation of Immune-Related Adverse Events and Response From Immune Checkpoint Inhibitors in Patients With Advanced NSCLC

P3.04-14 TMB and Immune Checkpoint Inhibitor Gene Expression Are Unrelated in NSCLC Patients

P1.04-16 Comparison of Clinical Response to Checkpoint Inhibitors in Advanced NSCLC With High PD-L1 Expression Tested on Cytology Versus Biopsy Samples

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

MA19.08 Detection of Primary Immunotherapy Resistance to PD-1 Checkpoint Inhibitors (PD1CI) in 2nd Line NSCLC

Prognostic Impact of Tumor Cell PD-L1 Expression and Immune Cell Infiltration in NSCLC

P3.04-04 Prognostic Value of MHC-I, PD-L1 and CD8+ TILs Expressions in Patients With Surgically Resected Non-Small Cell Lung Cancer

P1.01-08 Hyperresponsive Disease: A New Pattern of Response in NSCLC Patients Treated by Anti-Pd-1/Pd-L1